Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chiauranib in advanced or unresectable soft tissue sarcoma after standard therapy failure
CTR20221212Phase 2Completed
- Sponsor
- Akeso, Inc.
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chiauranib in soft tissue sarcoma (STS), sponsored by Akeso, Inc.. Started Jun 2022; status: completed.
02
Drugs
chiauranib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on CTR20221212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221212.